Drug Designing and Biomarkers

biomarker is an attribute which will be studied as an indicator of pathogenic and biological operation alongside pharmacological retort to a therapeutic involvement. They indicate either normal or diseased activity within the body. Biomarkers are specific molecules, genes, gene products, hormones, cells or enzymes.

Drug Designing is an ingenious process to seek out new medication centered on the knowledge of biological target. Drug is most ordinarily a little molecule that inhibits or activates the function of a biomolecule, which successively outcomes during a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This sort of modelling is usually mentioned to as computer-aided drug design.

  • Drug targets
  • Ligand-based design
  • Structure-based design
  • Computer-aided drug design
  • Scoring functions

    Related Conference of Drug Designing and Biomarkers

    January 19-20, 2026

    17th International Conference on Biofuels and Bioenergy

    Barcelona, Spain
    May 04-05, 2026

    7th International Conference on Drug Chemistry

    Paris, France
    September 03-04, 2026

    16th World Glycobiology Congress

    Aix-en-Provence, France
    September 21-22, 2026

    24th International Conference on Structural Biology

    A Coruna, Spain

    Drug Designing and Biomarkers Conference Speakers